Creation of a S1P Lyase bacterial surrogate for structure-based drug design

Argiriadi, Maria A.; Banach, David; Radziejewska, Elzbieta; Marchie, Susan; DiMauro, Jennifer; Dinges, Jurgen; Dominguez, Eric; Hutchins, Charles; Judge, Russell A.; Queeney, Kara; Wallace, Grier; Harris, Christopher M.

doi:10.1016/j.bmcl.2016.02.084

Title: Creation of a S1P Lyase bacterial surrogate for structure-based drug design

Authors:: Argiriadi, Maria A.; Banach, David; Radziejewska, Elzbieta; Marchie, Susan; DiMauro, Jennifer; Dinges, Jurgen; Dominguez, Eric; Hutchins, Charles; Judge, Russell A.; Queeney, Kara; Wallace, Grier; Harris, Christopher M.

Publication Date:: Sun May 01 00:00:00 EDT 2016

Sponsoring Org.:: USDOE

OSTI Identifier:: 1358847

Grant/Contract Number:: AC02-06CH11357

Resource Type:: Publisher's Accepted Manuscript

Journal Name:: Bioorganic and Medicinal Chemistry Letters

Additional Journal Information:: Journal Name: Bioorganic and Medicinal Chemistry Letters Journal Volume: 26 Journal Issue: 9; Journal ID: ISSN 0960-894X

Publisher:: Elsevier

Country of Publication:: United Kingdom

Language:: English

Citation Formats


                    Argiriadi, Maria A., Banach, David, Radziejewska, Elzbieta, Marchie, Susan, DiMauro, Jennifer, Dinges, Jurgen, Dominguez, Eric, Hutchins, Charles, Judge, Russell A., Queeney, Kara, Wallace, Grier, and Harris, Christopher M. Creation of a S1P Lyase bacterial surrogate for structure-based drug design.  United Kingdom: N. p., 2016. 
Web.  doi:10.1016/j.bmcl.2016.02.084.

Copy to clipboard


                    Argiriadi, Maria A., Banach, David, Radziejewska, Elzbieta, Marchie, Susan, DiMauro, Jennifer, Dinges, Jurgen, Dominguez, Eric, Hutchins, Charles, Judge, Russell A., Queeney, Kara, Wallace, Grier, & Harris, Christopher M. Creation of a S1P Lyase bacterial surrogate for structure-based drug design.  United Kingdom.  https://doi.org/10.1016/j.bmcl.2016.02.084

Copy to clipboard


                    Argiriadi, Maria A., Banach, David, Radziejewska, Elzbieta, Marchie, Susan, DiMauro, Jennifer, Dinges, Jurgen, Dominguez, Eric, Hutchins, Charles, Judge, Russell A., Queeney, Kara, Wallace, Grier, and Harris, Christopher M. Sun .  
"Creation of a S1P Lyase bacterial surrogate for structure-based drug design".  United Kingdom.  https://doi.org/10.1016/j.bmcl.2016.02.084.

Copy to clipboard


                    
@article{osti_1358847,

  title        = {Creation of a S1P Lyase bacterial surrogate for structure-based drug design},

  author       = {Argiriadi, Maria A. and Banach, David and Radziejewska, Elzbieta and Marchie, Susan and DiMauro, Jennifer and Dinges, Jurgen and Dominguez, Eric and Hutchins, Charles and Judge, Russell A. and Queeney, Kara and Wallace, Grier and Harris, Christopher M.},

  abstractNote = {},

  doi          = {10.1016/j.bmcl.2016.02.084},

  journal      = {Bioorganic and Medicinal Chemistry Letters},

  number       = 9,

  volume       = 26,

  place        = {United Kingdom},

  year         = {Sun May 01 00:00:00 EDT 2016},

  month        = {Sun May 01 00:00:00 EDT 2016}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Accepted Manuscript (Publisher)

Publisher's Version of Record
https://doi.org/10.1016/j.bmcl.2016.02.084

Other availability

Search WorldCat to find libraries that may hold this journal

Citation Metrics:

Cited by: 9 works

Citation information provided by
Web of Science

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Synthesis of a Fluorogenic Analogue of Sphingosine-1-Phosphate and Its Use to Determine Sphingosine-1-Phosphate Lyase Activity
journal, March 2009

Bedia, Carmen; Camacho, Luz; Casas, Josefina
ChemBioChem, Vol. 10, Issue 5
DOI: 10.1002/cbic.200800809

Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders
journal, July 2009

Bagdanoff, Jeffrey T.; Donoviel, Michael S.; Nouraldeen, Amr
Journal of Medicinal Chemistry, Vol. 52, Issue 13
DOI: 10.1021/jm900278w

Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
journal, January 2009

Vogel, Peter; Donoviel, Michael S.; Read, Robert
PLoS ONE, Vol. 4, Issue 1
DOI: 10.1371/journal.pone.0004112

Structure and Function of Sphingosine-1-Phosphate Lyase, a Key Enzyme of Sphingolipid Metabolism
journal, August 2010

Bourquin, Florence; Riezman, Howard; Capitani, Guido
Structure, Vol. 18, Issue 8
DOI: 10.1016/j.str.2010.05.011

Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
journal, September 2005

Schwab, S. R.
Science, Vol. 309, Issue 5741
DOI: 10.1126/science.1113640

Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis
journal, May 2014

Weiler, Sven; Braendlin, Nadine; Beerli, Christian
Journal of Medicinal Chemistry, Vol. 57, Issue 12
DOI: 10.1021/jm500338n

Similar Records in DOE PAGES and OSTI.GOV collections:

Creation of a S1P Lyase bacterial surrogate for structure-based drug design

Journal Article Argiriadi, Maria A. ; Banach, David ; Radziejewska, Elzbieta ; ... - Bioorg. Med. Chem. Lett.
https://doi.org/10.1016/j.bmcl.2016.02.084
Legionella pneumophila S1P-lyase targets host sphingolipid metabolism and restrains autophagy

Journal Article Rolando, Monica ; Escoll, Pedro ; Nora, Tamara ; ... - Proceedings of the National Academy of Sciences of the United States of America

Autophagy is an essential component of innate immunity, enabling the detection and elimination of intracellular pathogens. Legionella pneumophila, an intracellular pathogen that can cause a severe pneumonia in humans, is able to modulate autophagy through the action of effector proteins that are translocated into the host cell by the pathogen’s Dot/Icm type IV secretion system. Many of these effectors share structural and sequence similarity with eukaryotic proteins. Indeed, phylogenetic analyses have indicated their acquisition by horizontal gene transfer from a eukaryotic host. Here we report that L. pneumophila translocates the effector protein sphingosine-1 phosphate lyase (LpSpl) to target the hostmore »« less
Cited by 101
https://doi.org/10.1073/pnas.1522067113

Full Text Available
Complexes of Bacterial Nicotinate Mononucleotide Adenylyltransferase with Inhibitors: Implication for Structure-Based Drug Design and Improvement

Journal Article Huang, Nian ; Kolhatkar, Rohit ; Eyobo, Yvonne ; ... - J. Med. Chem.

Bacterial nicotinate mononucleotide adenylyltransferase encoded by the essential gene nadD plays a central role in the synthesis of the redox cofactor NAD{sup +}. The NadD enzyme is conserved in the majority of bacterial species and has been recognized as a novel target for developing new and potentially broad-spectrum antibacterial therapeutics. Here we report the crystal structures of Bacillus anthracis NadD in complex with three NadD inhibitors, including two analogues synthesized in the present study. These structures revealed a common binding site shared by different classes of NadD inhibitors and explored the chemical environment surrounding this site. The structural data obtainedmore »« less
https://doi.org/10.1021/jm100377f
Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design

Journal Article Hughes, Norman E. ; Bleisch, Thomas J. ; Jones, Scott A. ; ... - Bioorganic and Medicinal Chemistry Letters
Cited by 10
https://doi.org/10.1016/j.bmcl.2016.05.056
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2

Journal Article McBride, Christopher ; Cheruvallath, Zacharia ; Komandla, Mallareddy ; ... - Bioorganic and Medicinal Chemistry Letters
Cited by 16
https://doi.org/10.1016/j.bmcl.2016.04.072

Similar Records

Title: Creation of a S1P Lyase bacterial surrogate for structure-based drug design

Citation Formats

Synthesis of a Fluorogenic Analogue of Sphingosine-1-Phosphate and Its Use to Determine Sphingosine-1-Phosphate Lyase Activity journal, March 2009

Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders journal, July 2009

Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions journal, January 2009

Structure and Function of Sphingosine-1-Phosphate Lyase, a Key Enzyme of Sphingolipid Metabolism journal, August 2010

Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients journal, September 2005

Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis journal, May 2014

Synthesis of a Fluorogenic Analogue of Sphingosine-1-Phosphate and Its Use to Determine Sphingosine-1-Phosphate Lyase Activity
journal, March 2009

Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders
journal, July 2009

Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
journal, January 2009

Structure and Function of Sphingosine-1-Phosphate Lyase, a Key Enzyme of Sphingolipid Metabolism
journal, August 2010

Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
journal, September 2005

Orally Active 7-Substituted (4-Benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as Active-Site Inhibitors of Sphingosine 1-Phosphate Lyase for the Treatment of Multiple Sclerosis
journal, May 2014